5.515
前日終値:
$5.56
開ける:
$5.5
24時間の取引高:
1.52M
Relative Volume:
0.41
時価総額:
$1.00B
収益:
$2.51B
当期純損益:
$-171.15M
株価収益率:
-5.7251
EPS:
-0.9633
ネットキャッシュフロー:
$122.59M
1週間 パフォーマンス:
-2.73%
1か月 パフォーマンス:
-11.90%
6か月 パフォーマンス:
+4.65%
1年 パフォーマンス:
-39.33%
Teladoc Health Inc Stock (TDOC) Company Profile
Compare TDOC vs VEEV, BTSG, TEM, HNGE, HQY
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
TDOC
Teladoc Health Inc
|
5.515 | 1.00B | 2.51B | -171.15M | 122.59M | -0.9633 |
|
VEEV
Veeva Systems Inc
|
285.08 | 46.16B | 3.32B | 941.65M | 1.64B | 5.6161 |
|
BTSG
Brightspring Health Services Inc
|
63.60 | 12.58B | 13.65B | 169.86M | 412.12M | 1.0758 |
|
TEM
Tempus Ai Inc
|
67.67 | 12.28B | 1.36B | -302.91M | -219.93M | -1.7182 |
|
HNGE
Hinge Health Inc
|
98.25 | 7.93B | 646.34M | -512.40M | 202.76M | -6.6871 |
|
HQY
Healthequity Inc
|
93.00 | 7.69B | 1.34B | 230.70M | 440.96M | 2.6695 |
Teladoc Health Inc Stock (TDOC) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-03-10 | アップグレード | Deutsche Bank | Hold → Buy |
| 2026-02-26 | アップグレード | BofA Securities | Neutral → Buy |
| 2025-12-09 | 開始されました | Barclays | Equal Weight |
| 2025-11-13 | 開始されました | BMO Capital Markets | Market Perform |
| 2025-07-25 | 開始されました | Mizuho | Neutral |
| 2024-11-15 | 開始されました | Goldman | Buy |
| 2024-09-17 | 繰り返されました | Jefferies | Hold |
| 2024-02-29 | 開始されました | Cantor Fitzgerald | Overweight |
| 2024-02-26 | 開始されました | Leerink Partners | Market Perform |
| 2024-01-17 | ダウングレード | DA Davidson | Buy → Neutral |
| 2024-01-03 | 開始されました | Barclays | Overweight |
| 2023-04-12 | 開始されました | Stephens | Equal-Weight |
| 2023-02-23 | アップグレード | SVB Securities | Market Perform → Outperform |
| 2022-10-24 | アップグレード | Guggenheim | Sell → Neutral |
| 2022-09-16 | 開始されました | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | 開始されました | Truist | Hold |
| 2022-08-17 | ダウングレード | Guggenheim | Neutral → Sell |
| 2022-08-12 | 開始されました | DA Davidson | Buy |
| 2022-08-02 | ダウングレード | Berenberg | Buy → Hold |
| 2022-08-02 | ダウングレード | Cowen | Outperform → Market Perform |
| 2022-07-28 | ダウングレード | Goldman | Buy → Neutral |
| 2022-07-28 | ダウングレード | Needham | Buy → Hold |
| 2022-07-06 | 繰り返されました | BofA Securities | Neutral |
| 2022-05-05 | ダウングレード | Argus | Buy → Hold |
| 2022-04-28 | ダウングレード | Citigroup | Buy → Neutral |
| 2022-04-28 | ダウングレード | Credit Suisse | Outperform → Neutral |
| 2022-04-28 | ダウングレード | Guggenheim | Buy → Neutral |
| 2022-04-28 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2022-04-28 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2022-04-28 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2022-04-28 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2022-04-07 | 開始されました | Guggenheim | Buy |
| 2022-04-01 | 再開されました | Credit Suisse | Outperform |
| 2022-03-03 | アップグレード | Argus | Hold → Buy |
| 2022-02-23 | 繰り返されました | BofA Securities | Neutral |
| 2022-02-23 | 繰り返されました | Craig Hallum | Hold |
| 2022-02-23 | 繰り返されました | Evercore ISI | In-line |
| 2022-02-23 | 繰り返されました | Goldman | Buy |
| 2022-02-23 | 繰り返されました | JP Morgan | Overweight |
| 2022-02-23 | 繰り返されました | KeyBanc Capital Markets | Overweight |
| 2022-02-23 | 繰り返されました | Needham | Buy |
| 2022-02-23 | 繰り返されました | Oppenheimer | Outperform |
| 2022-02-23 | 繰り返されました | Stifel | Hold |
| 2022-02-11 | 開始されました | Goldman | Buy |
| 2022-02-08 | 繰り返されました | Piper Sandler | Overweight |
| 2021-12-02 | 再開されました | Jefferies | Hold |
| 2021-11-22 | ダウングレード | BTIG Research | Buy → Neutral |
| 2021-10-28 | 繰り返されました | Barclays | Equal Weight |
| 2021-10-28 | 繰り返されました | BofA Securities | Neutral |
| 2021-10-28 | 繰り返されました | Canaccord Genuity | Buy |
| 2021-10-28 | 繰り返されました | Citigroup | Buy |
| 2021-10-28 | 繰り返されました | Craig Hallum | Hold |
| 2021-10-28 | 繰り返されました | Needham | Buy |
| 2021-10-28 | 繰り返されました | Oppenheimer | Outperform |
| 2021-10-28 | 繰り返されました | Piper Sandler | Overweight |
| 2021-10-28 | 繰り返されました | UBS | Neutral |
| 2021-10-19 | 開始されました | Wells Fargo | Overweight |
| 2021-08-02 | ダウングレード | Argus | Buy → Hold |
| 2021-07-28 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2021-05-28 | 開始されました | Robert W. Baird | Neutral |
| 2021-04-15 | 開始されました | Needham | Buy |
| 2021-01-07 | 開始されました | BTIG Research | Buy |
| 2020-12-22 | 開始されました | Evercore ISI | In-line |
| 2020-12-07 | ダウングレード | Stephens | Overweight → Equal-Weight |
| 2020-12-04 | 開始されました | Goldman | Neutral |
| 2020-11-13 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2020-09-22 | 開始されました | DA Davidson | Buy |
| 2020-09-02 | アップグレード | Berenberg | Hold → Buy |
| 2020-08-17 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2020-07-14 | 開始されました | Citigroup | Buy |
| 2020-07-13 | 開始されました | Argus | Buy |
| 2020-07-07 | 開始されました | Stephens | Overweight |
| 2020-04-30 | 繰り返されました | KeyBanc Capital Markets | Overweight |
| 2020-04-13 | 開始されました | SVB Leerink | Outperform |
| 2020-03-31 | ダウングレード | Berenberg | Buy → Hold |
| 2020-03-25 | ダウングレード | Craig Hallum | Buy → Hold |
| 2020-03-16 | アップグレード | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-03-12 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2020-02-28 | ダウングレード | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-02-12 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2020-01-10 | 開始されました | UBS | Neutral |
| 2020-01-09 | ダウングレード | BofA/Merrill | Buy → Neutral |
すべてを表示
Teladoc Health Inc (TDOC) 最新ニュース
Teladoc (TDOC) Sees a More Significant Dip Than Broader Market: Some Facts to Know - Zacks Investment Research
3 Undervalued Healthcare Stocks Invstors Can Buy Right Now - The Motley Fool
Teladoc (TDOC) Sees a More Significant Dip Than Broader Market: Some Facts to Know - Zacks Investment Research
Teladoc Health stock falls 3.46 percent after weak Q2 revenue - ad-hoc-news.de
Teladoc (TDOC) Registers a Bigger Fall Than the Market: Important Facts to Note - Zacks Investment Research
Teladoc Health stock holds near USD 6.26 as revenue pressure persists - AD HOC NEWS
Teladoc Health CEO Charles Divita sells $108,681 in shares By Investing.com - Investing.com South Africa
Teladoc Health CEO Charles Divita sells $108,681 in shares - Investing.com
The Bull Case For Teladoc Health (TDOC) Could Change Following Weak Q2 Results And Lowered Guidance - finance.yahoo.com
Teladoc Health (TDOC) Slips 2.20% to $6.43, Drifting Toward Key SupportInstitutional Volume - careplusvn.com
Teladoc Share PriceTDOC, RNS News, Articles, Quotes, & Charts (NYSE:TDOC) - Proactive financial news
Teladoc: Integrated Care And Free Cash Flow Could Bring It Back To Life - Seeking Alpha
Teladoc Health | 144: Notice of proposed sale of securities pursuant to Rule 144 - moomoo.com
Why Teladoc (TDOC) Outpaced the Stock Market Today - Yahoo Finance
Teladoc Health (TDOC) executive plans 17.8K-share stock sale - Stock Titan
Avoiding Lag: Real-Time Signals in (TDOC) Movement - Stock Traders Daily
2 Beaten-Down Stocks to Avoid Right Now - The Globe and Mail
2 Beaten-Down Stocks to Avoid Right Now - finance.yahoo.com
2 Beaten-Down Stocks to Avoid Right Now - theglobeandmail.com
Here's Why Teladoc's Integrated Care Business Deserves More Attention - The Globe and Mail
Here's Why Teladoc's Integrated Care Business Deserves More Attention - TradingView
Here's Why Teladoc's Integrated Care Business Deserves More Attention - Yahoo Finance
Teladoc Health | 4: Statement of changes in beneficial ownership of securities-Officer Bliss Kelly - Moomoo
Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08 - GlobeNewswire
Teladoc Health (TDOC) CEO sells 18,327 shares after stock awards vest - Stock Titan
Equity awards vest for Teladoc Health (NYSE: TDOC) accounting chief - Stock Titan
15,311 stock units vest for Teladoc (TDOC) exec as she sells shares for taxes - Stock Titan
Teladoc Health (TDOC) exec sells shares to cover taxes after 14,928 units vest - Stock Titan
RSU vesting prompts Teladoc (TDOC) executive to sell shares for taxes - Stock Titan
Teladoc Health (NYSE: TDOC) president sells 15,251 shares - Stock Titan
Teladoc Health | 144: Notice of proposed sale of securities pursuant to Rule 144 - Moomoo
Teladoc Health (NYSE: TDOC) officer plans sale of 9,812 recently vested shares - Stock Titan
The Escalator: GSK, Teladoc, FINN Partners and more - Medical Marketing and Media
Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08 - Yahoo Finance
Teladoc Health | 144: Notice of proposed sale of securities pursuant to Rule 144 - Moomoo
Planned stock sale by Teladoc (NYSE: TDOC) officer covers 7,357 shares - Stock Titan
Teladoc Health (NYSE: TDOC) insider lines up 5,439-share stock sale tied to vested awards - Stock Titan
Teladoc (NYSE: TDOC) exec plans stock sale, including shares to cover taxes on vested stock - Stock Titan
Teladoc (NYSE: TDOC) officer plans $39K stock sale - Stock Titan
Teladoc Health (NYSE: TDOC) holder plans 18,327-share Rule 144 sale - Stock Titan
Teladoc Health (NYSE: TDOC) Names Grasher Michael F as CFO and Records New Insider Status - Kalkine Media
Teladoc Health stock rises on a new CFO and steady July results - AD HOC NEWS
Here's Why Investors Should Stay Neutral on TDOC Stock for Now - TradingView
Here's Why Investors Should Stay Neutral on TDOC Stock for Now - Yahoo Finance
Teladoc Health CFO Michael F. Grasher Granted 239,616 Restricted Stock Units on September 1, 2026 - Kalkine Media
Teladoc Health Appoints Michael Grasher as New CFO - theglobeandmail.com
Insider at Teladoc (TDOC) reports new stock trades - Stock Titan
Teladoc (NYSE: TDOC) CFO Michael Grasher listed as insider with no trades reported - Stock Titan
What Teladoc Health (TDOC)'s New Insurance-Focused CFO Appointment Means For Shareholders - simplywall.st
CCORF Maintains Teladoc Health(TDOC.US) With Buy Rating, Maintains Target Price $10 - moomoo.com
Teladoc Health Inc (TDOC) 財務データ
収益
当期純利益
現金流量
EPS
Teladoc Health Inc (TDOC) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| DIVITA CHARLES III | Officer |
Sep 11 '26 |
Proposed Sale |
6.10 |
17,805 |
108,684 |
0 |
| DIVITA CHARLES III | CHIEF EXECUTIVE OFFICER |
Sep 11 '26 |
Sale |
6.10 |
17,805 |
108,682 |
465,535 |
| Rodrigues Fernando M. | Officer |
Sep 03 '26 |
Proposed Sale |
6.51 |
9,812 |
63,876 |
0 |
| DIVITA CHARLES III | CHIEF EXECUTIVE OFFICER |
Sep 02 '26 |
Sale |
6.30 |
18,327 |
115,478 |
440,538 |
| Bliss Kelly | Officer |
Sep 02 '26 |
Proposed Sale |
6.30 |
7,357 |
46,359 |
0 |
| DIVITA CHARLES III | Officer |
Sep 02 '26 |
Proposed Sale |
6.30 |
18,327 |
115,484 |
0 |
| Nueno Carlos | Officer |
Sep 02 '26 |
Proposed Sale |
6.30 |
6,200 |
39,068 |
0 |
| Vandervoort Adam C | Officer |
Sep 02 '26 |
Proposed Sale |
6.30 |
7,573 |
47,720 |
0 |
| Rodrigues Fernando M. | Officer |
Sep 02 '26 |
Proposed Sale |
6.30 |
5,439 |
34,273 |
0 |
| Nueno Carlos | President, International |
Sep 02 '26 |
Sale |
6.30 |
6,200 |
39,066 |
64,744 |
大文字化:
|
ボリューム (24 時間):